TUULIKKI SOKKA-ISLER

Yhteystiedot

Julkaisut

• Thalmann, Reto; von Kempis, Johannes; Zgraggen, Armin; Graf, Nicole; Schiff, Michael; Sokka, Tuulikki; Dietrich, Tobias; Schulze-Koops, Hendrik; Mueller, Ruediger B. 2022. Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high worsening of patient-related outcomes Clinical and experimental rheumatology [May 5. Online ahead of print]: -. 2022
• Hiltunen, J; Parmanne, P; Sokka, T; Lamberg, T; Isomäki, P; Kaipiainen-Seppänen, O; Peltomaa, R; Uutela, T; Pirilä, L; Taimen, K; Kauppi, MJ; Yli-Kerttula, T; Tuompo, R; Relas, H; Kortelainen, S; Paalanen, K; Asikainen, J; Ekman, P; Santisteban, A; Vidqvist, K-L; et al.for the FinADASpA Study Group. 2021. Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis Rheumatology international [Epub ahead of print 6 Aug 2021]: 1-11. 2021
• Weman, Lauri; Sokka-Isler, Tuulikki. 2021. Nivelreuma tunnistetaan entistä aiemmin Duodecim 137 15: 1549 - 1556. 2021
• Kuusalo, Laura; Sokka-Isler, Tuulikki; Kautiainen, Hannu; Ekman, Päivi; Kauppi, Markku J; Pirilä, Laura; Rannio, Tuomas; Uutela, Toini; Yli-Kerttula, Timo; Puolakka, Kari; The SandRA Study Group. 2020. Automated text message enhanced monitoring versus routine monitoring in early rheumatoid arthritis: a randomized trial Arthritis care and research 72 3: 319-325. 2020
• Hetland, Merete Lund; Haavardsholm, Espen A; Rudin, Anna; Nordström, Dan; Nurmohamed, Michael; Gudbjornsson, Bjorn; Lampa, Jon; Hørslev-Petersen, Kim; Uhlig, Till; Grondal, Gerdur; Østergaard, Mikkel; Heiberg, Marte S; Twisk, Jos; Lend, Kristina; Krabbe, Simon; Hyldstrup, Lise Hejl; Lindqvist, Joakim; Hultgård Ekwall, Anna-Karin; Grøn, Kathrine Lederballe; Kapetanovic, Meliha; et al. [incl; Sokka-. 2020. Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial BMJ 371 8271: m4328. 2020
• Paalanen, K; Rannio, K; Rannio, T; Asikainen, J; Hannonen, P; Sokka, T. 2020. Prevalence of calcium pyrophosphate deposition disease in a cohort of patients diagnosed with seronegative rheumatoid arthritis Clinical and experimental rheumatology 38 1: 99-106. 2020
• Paalanen, Kirsi; Puolakka, Kari; Nikiphorou, Elena; Hannonen, Pekka; Sokka, Tuulikki. 2020. Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study Rheumatology 2021; 60 5: 2391-2395. 2020
• Kelkka, Tiina; Savola, Paula; Bhattacharya, Dipabarna; Huuhtanen, Jani; Lönnberg, Tapio; Kankainen, Matti; Paalanen, Kirsi; Tyster, Mikko; Lepistö, Maija; Ellonen, Pekka; Smolander, Johannes; Eldfors, Samuli; Yadav, Bhagwan; Khan, Sofia; Koivuniemi, Riitta; Sjöwall, Christopher; Elo, Laura L; Lähdesmäki, Harri; Maeda, Yuka; Nishikawa, Hiroyashi; et al. [incl. Sokka-Isler, Tuulikki]. 2020. Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature Frontiers in immunology 11: 578848. 2020
• Keinänen, Mika; Brummer-Korvenkontio, Henrikki; Eskola, Markku; Ettala, Otto; Hartikainen, Juha; Hovi, Petteri; Isosomppi, Sanna; Kivelä, Pia; Kärki, Johanna; Kärkkäinen, Jukka; Laatikainen, Tiina; Liukko, Emmi; Niemi, Anu; Mattila, Elina; Meriläinen, Merja; Mustonen, Pirjo; Pekkanen, Liisa; Puolakka, Kari; Relas, Heikki; Sainio, Salla [incl. Sokka-Isler, Tuulikki]. 2020. Terveydenhuollon kansalliset laaturekisteripilotit loppusuoralla Lääkärilehti 75 50: 2788 - 2791. 2020
• Kauppi, Markku; Kononoff, Aulikki; Puolakka, Kari; Valleala, Heikki; Pettersson, Tom; Sokka-Isler, Tuulikki. 2020. Jättisoluarteriitin uusi lääke pitää saada korvattavaksi suomalaispotilaillekin Lääkärilehti 75 22: 1351-1353. 2020
• Kariniemi, Simo; Rantalaiho, Vappu; Virta, Lauri J; Puolakka, Kari; Sokka-Isler, Tuulikki; Elfving, Pia. 2020. Multimorbidity among incident Finnish systemic lupus erythematosus patients during 2000-2017 Lupus 2021; 30 1: 165-171. 2020
• Mars, NJ; Kerola, AM; Kauppi, MJ; Pirinen, M; Elonheimo, O; Sokka-Isler, T. 2019. Patients with rheumatic diseases share similar patterns of healthcare resource utilization Scandinavian journal of rheumatology 48 4: 300-307. 2019
• Nikiphorou, E; Hannonen, P; Asikainen, J; Borodina, J; Kokko, A; Paalanen, K; Rannio, T; Sokka, T. 2019. Survival and safety of infliximab bio-original and infliximab biosimilar (CT-P13) in usual rheumatology care Clinical and experimental rheumatology 37 1: 55-59. 2019
• Paalanen, K; Rannio, K; Rannio, T; Asikainen, J; Hannonen, P; Sokka, T. 2019. Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study Clinical and experimental rheumatology 37 1: 37-43. 2019
• Putrik, P; Ramiro, S; Guillemin, F; Péntek, M; Sivera, F; Sokka, T; de Wit, M; Woolf, AD; Zink, A; Andersone, D; Berghea, F; Butrimiene, I; Brouwer, S; Cassar, K; Charalambous, P; Caporali, R; Deseatnicova, E; Damjanov, NS; Finckh, A; FitzGerald, O; et al.. 2019. Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries Annals of the rheumatic diseases 78 11: 1472-1479. 2019
• Mars, NJ; Kerola, AM; Kauppi, MJ; Pirinen, M; Elonheimo, O; Sokka-Isler, T. 2019. Healthcare costs and outcomes in adult patients with juvenile idiopathic arthritis: a population-based study Scandinavian journal of rheumatology 48 2: 114-120. 2019
• Heinimann, K; von Kempis, J; Sauter, R; Schiff, M; Sokka-Isler, T; Schulze-Koops, H; Müller, R. 2018. Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort. Journal of Clinical Medicine 7 3: 57. 2018
• Targeting Comorbidity in Routine Rheumatology Care. Sokka-Isler, Tuulikki / Comorbidity in Rheumatic Diseases. 2018. 2018
• Pirilä Laura, Sokka Tuulikki, Kauppi Markku J, Rantalaiho Vappu M, Mervaala Eero, Puolakka Kari. 2017. Alternative interpretation of data for recommendations on how to manage rheumatoid arthritis. ANNALS OF THE RHEUMATIC DISEASES 76 12: e49. 2017
• Rantalaiho Vappu, Sokka Tuulikki, Meri Seppo. 2017. Nivelreuma. DUODECIM 133 18: 1691-1698. 2017
• Rannio T, Asikainen J, Hannonen P, Yli-Kerttula T, Ekman P, Pirilä L, Kuusalo L, Mali M, Puurtinen-Vilkki M, Kortelainen S, Paltta J, Taimen K, Kauppi M, Laiho K, Nyrhinen S, Mäkinen H, Isomäki P, Uotila T, Aaltonen K, Kautiainen H et al. 2017. Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 46 6: 425-431. 2017
• Nikiphorou E, Galloway J, van Riel P, Yazici Y, Haugeberg G, Ostor A, Gogus F, Kauppi M, Sokka T. 2017. The spectrum of early rheumatoid arthritis practice across the globe: results from a multinational cross sectional survey. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 35 3: 477-483. 2017
• Pincus Theodore, Block Joel A, Yazici Yusuf, Bergman Martin J, Sokka Tuulikki. 2017. Comment on article by Fleischman et al and accompanying editorial by Davis concerning the multi-biomarker disease activity (MBDA) Vectra assay. ARTHRITIS AND RHEUMATISM 69 4: 866-867. 2017
• Nikiphorou Elena, Uksila Jaakko, Sokka Tuulikki. 2017. A cross-sectional study of vitamin D levels in a large cohort of patients with rheumatic diseases. CLINICAL RHEUMATOLOGY 2018; 37 3: 803-810. 2017
• Khan Nasim Ahmed, Spencer Horace Jack, Nikiphorou Elena, Naranjo Antonio, Alten Rieki, Chirieac Rodica M, Drosos Alexandros A, Géhér Pal, Inanc Nevsun, Kerzberg Eduardo, Ancuta Codrina Mihaela, Muller Ruediger, Ornbjerg Lykke, Sokka Tuulliki. 2017. Intercentre variance in patient reported outcomes is lower than objective rheumatoid arthritis activity measures: a cross-sectional study. RHEUMATOLOGY 56 8: 1395-1400. 2017
• Aaltonen Kalle, Heinonen Aarto, Joensuu Jaana, Parmanne Pinja, Karjalainen Anna, Varjolahti-Lehtinen Tuire, Uutela Toini, Puurtinen-Vilkki Maija, Arstila Leena, Blom Marja, Sokka Tuulikki, Nordström Dan. 2017. Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort study. SEMINARS IN ARTHRITIS AND RHEUMATISM 46 6: 732-739. 2017
• Väre Paula, Nikiphorou Elena, Hannonen Pekka, Sokka Tuulikki. 2016. Delivering a one-stop, integrated, and patient-centered service for patients with rheumatic diseases. SAGE Open Medicine 4: 1-7. 2016
• Sokka T. 2016. Go, go, GoTreatlT!. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 34 5 (Suppl. 101): 91-95. 2016
• Sokka T. 2016. Go, go, Go Treat IT!. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 34 Suppl. 101: S91-S95. 2016
• Smolen Josef S, Collaud Basset Sabine, Boers Maarten, Breedveld Ferdinand, Edwards Christopher J, Kvien Tore K, Miossec Pierre, Sokka-Isler Tuulikki, van Vollenhoven Ronald F, Abadie Eric C, Bruyère Olivier, Cooper Cyrus, Mäkinen Heidi, Thomas Thierry, Tugwell Peter, Reginster Jean-Yves. 2016. Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease. ANNALS OF THE RHEUMATIC DISEASES 75 7: 1268-1271. 2016
• Smolen Josef S, Breedveld Ferdinand C, Burmester Gerd R, Bykerk Vivian, Dougados Maxime, Emery Paul, Kvien Tore K, Navarro-Compán M Victoria, Oliver Susan, Schoels Monika, Scholte-Voshaar Marieke, Stamm Tanja, Stoffer Michaela, Takeuchi Tsutomu, Aletaha Daniel, Andreu Jose Louis, Aringer Martin, Bergman Martin, Betteridge Neil, Bijlsma Hans et al. 2016. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. ANNALS OF THE RHEUMATIC DISEASES 75 1: 3-15. 2016
• Nikiphorou Elena, Sjöwall Christopher, Hannonen Pekka, Rannio Tuomas, Sokka Tuulikki. 2016. Long-term outcomes of destructive seronegative (rheumatoid) arthritis - description of four clinical cases. BMC MUSCULOSKELETAL DISORDERS 17: 246. 2016
• Rannio Tuomas, Asikainen Juha, Kokko Arto, Hannonen Pekka, Sokka Tuulikki. 2016. Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis. Journal of Rheumatology 43 4: 699-706. 2016
• Kröger Liisa, Molander Pauliina, Mälkönen Tarja, Sokka-Isler Tuulikki. 2016. Vuosi vai vuosikymmeniä : jatkuuko biologinen lääkitys loppuelämän?. DUODECIM 132 4: 339-341. 2016
• Joensuu Jaana T, Aaltonen Kalle J, Aronen Pasi, Sokka Tuulikki, Puolakka Kari, Tuompo Riitta, Korpela Markku, Vasala Mikko, Ilva Kirsti, Nordström Dan, Blom Marja. 2016. Cost-effectiveness of biological compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study. RHEUMATOLOGY [epub ahead of print June 27, 2016]: -. 2016
• Asikainen J, Nikiphorou E, Kaarela K, Lindqvist E, Häkkinen A, Kautiainen H, Hannonen P, Rannio T, Sokka T. 2016. Is long-term radiographic joint damage different between men and women? Prospective longitudinal data analysis of four early RA cohorts with greater than 15 years follow-up.. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 34 4: 641-645. 2016
• Aaltonen KJ, Turunen JH, Sokka T, Puolakka K, Valleala H. 2016. A survey on the medication adherence to methotrexate among rheumatoid arthritis patients treated with self-administered biologic drugs. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 34 4: 0694-0697. 2016
• Aaltonen KJ, Joensuu JT, Pirilä L, Kauppi M, Uutela T, Varjolahti-Lehtinen T, Yli-Kerttula T, Isomäki P, Nordström D, Sokka T. 2016. Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 2017; 46 5: 359-363. 2016
• Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB, MEASURE 1 Study Group, MEASURE 2 Study Group (incl. Sokka-Isler T). 2015. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. NEW ENGLAND JOURNAL OF MEDICINE 2016; 373: 2534-2548. 2015
• Nikiphorou Elena, Rannio Tuomas, Sokka Tuulikki. 2015. Rheumatoid arthritis in the 21st century: treatment patterns and disease activity states. JOURNAL OF RHEUMATOLOGY 42 9: 1542-1544. 2015
• Ormseth Michelle J, Chung Cecilia P, Oeser Annette M, Connelly Margery A, Sokka Tuulikki, Raggi Paolo, Solus Joseph F, Otvos James D, Stein C Michael. 2015. Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis. ARTHRITIS RESEARCH & THERAPY [ONLINE: HTTP://ARTHRITIS-RESEARCH.COM/HOME/] 17: 117. 2015